Clinical Trials Browser

Phase 3 × Recurrence × Thalidomide × Clear all

NCT00256776 2021-10-18

MMVAR - Velcade: Study of Velcade for the Treatment of Myeloma Patients After Autologous Transplantation

Phase 3 Terminated

269 enrolled 9 charts

Multiple Myeloma, Recurrence

NCT00602511 2011-02-09

Thalidomide Versus Bortezomib in Melphalan Refractory Myeloma

Phase 3 Completed

Multiple Myeloma, Recurrence